Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Services
Return to: PBR Home | Contract Research & Services | Contract Services

Contract Services

Purdue Pharma, AnaBios partner to advance research for non-opioid, non-NSAID compounds Purdue Pharma and AnaBios have partnered to advance the research of non-opioid, non-NSAID compounds for the treatment of chronic pain.
Contract Research & Services > Contract Services > News
Aegerion Pharmaceuticals signs licensing deal with Amryt Pharma for Lojuxta Novelion Therapeutics' subsidiary, Aegerion Pharmaceuticals has entered into a licensing agreement with Amryt Pharma (“Amryt”) for the exclusive rights to LOJUXTA (lomitapide) hard capsules in certain European and Middle Eastern territories.
Contract Research & Services > Contract Services > News Natrix collaborates with Merck and Sanofi on Protein A Platform Natrix Separations has signed development agreements with Merck and Sanofi to advance its new membrane-based Protein A platform for antibody purification.
Contract Research & Services > Contract Services > News
See more Contract Services news

Latest Contract Services News and Insight

View all Contract Services news or find news targeted to your interests
Mylan signs deal with Medicines Patent Pool to expand access to hepatitis C medicines in developing countries
Mylan has signed an agreement with the Medicines Patent Pool (MPP) to expand access to chronic hepatitis C medicines in developing countries.
Contract Research & Services > Contract Services > News
Orchard Therapeutics and UCLA secure $20m funding from California’s stem cell agency
The California Institute for Regenerative Medicine’s governing board (CIRM) has awarded $20m to Orchard Therapeutics and researchers from the UCLA Broad Stem Cell Research, led by Orchard Scientific Advisory Board member Donald Kohn.
Contract Research & Services > Contract Services > News
BioLineRx secures rights to DES treatment from Hebrew University
BioLineRx has signed an exclusive, worldwide agreement with Yissum Research Development Company of the Hebrew University of Jerusalem, for the in-licensing of a novel anti-inflammatory treatment for Dry Eye Syndrome (DES).
Contract Research & Services > Contract Services > News
MedImmune completes out-licensing deal with Allergan for MEDI2070
AstraZeneca's global biologics research and development arm, MedImmune has completed out-licensing agreement with Allergan for the global rights to MEDI2070.
Contract Research & Services > Contract Services > News
Grünenthal acquires US-based Thar Pharmaceuticals
Germany-based Grünenthal has acquired US clinical-stage, specialty pharmaceutical firm Thar Pharmaceuticals.
Contract Research & Services > Contract Services > News
View all Contract Services news or find news targeted to your interests